SCHEMBL6423587

SCHEMBL6423587

CN(c1ccccc1)c1cc(Cl)ccc1N

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHKA P35790 7/20 0.51
KMT2A Q03164 2/20 0.46
GAA P10253 1/20 0.46
CSF1R P07333 1/20 0.44
CHKB Q9Y259 2/20 0.44
CYP3A4 P08684 4/20 0.42
TSHR P16473 3/20 0.42
ALOX15 P16050 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
ALDH1A1 P00352 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
GFER P55789 1/20 0.38
MAPK13 O15264 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3524418 0.86 GAA (0.59) CHKAKMT2AGAACSF1RCHKB
SCHEMBL29454136 0.79 CHKA (0.42) CHKAKMT2AGAACSF1RCHKB
SCHEMBL8378948 0.79 MAPT (0.41) CHKATSHRKDM4EMAPT
SCHEMBL3261175 0.79 CHKA (0.51) CHKAKMT2ACSF1RCHKBCYP3A4
SCHEMBL11752540 0.78 MAPK13 (0.49) CHKAKMT2AGAATSHRALOX15
SCHEMBL30936642 0.77 MAPK13 (0.43) CHKAKMT2ACYP3A4ALOX15SMN1; SMN2
SCHEMBL5741661 0.77 MAPK13 (0.43) CHKAKMT2ACYP3A4ALOX15SMN1; SMN2
SCHEMBL3214529 0.77 GAA (0.67) KMT2AGAACYP3A4TSHRALOX15
SCHEMBL9990446 0.76 CHKA (0.53) CHKAKMT2AGAACSF1RCHKB
SCHEMBL28674705 0.75 TSHR (0.49) CHKAKMT2ACSF1RCHKBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050171087-A1 Non-steroidal progesterone receptor modulators MERCK SHARP & DOHME B.V. (NL) 2005-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171087-A1 Non-steroidal progesterone receptor modulators PGR, PGRMC1, PGRMC2 CHKA 2181/4885KMT2A 2690/4885GAA 4509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.